Albert Einstein College of Medicine, Bronx, NY, USA.
Division of Respiratory and Sleep Medicine, Department of Pediatrics, Albert Einstein College of Medicine, Children's Hospital at Montefiore, 3415 Bainbridge Avenue, Bronx, NY, 10467-2490, USA.
Lung. 2020 Apr;198(2):257-270. doi: 10.1007/s00408-020-00342-5. Epub 2020 Mar 12.
Obstructive sleep apnea syndrome (OSAS) is a common pediatric disorder characterized by recurrent events of partial or complete upper airway obstruction during sleep which result in abnormal ventilation and sleep pattern. OSAS in children is associated with neurobehavioral deficits and cardiovascular morbidity which highlights the need for prompt recognition, diagnosis, and treatment. The purpose of this state-of-the-art review is to provide an update on the evaluation and management of children with OSAS with emphasis on children with complex medical comorbidities and those with residual OSAS following first-line treatment. Proposed treatment strategies reflecting recommendations from a variety of professional societies are presented. All children should be screened for OSAS and those with typical symptoms (e.g., snoring, restless sleep, and daytime hyperactivity) or risk factors (e.g., neurologic, genetic, and craniofacial disorders) should undergo further evaluation including referral to a sleep specialist or pediatric otolaryngologist and overnight polysomnography, which provides a definitive diagnosis. A cardiology and/or endocrinology evaluation should be considered in high-risk children. For the majority of children, first-line treatment is tonsillectomy with or without adenoidectomy; however, some children exhibit multiple levels of airway obstruction and may require additional evaluation and management. Anti-inflammatory medications, weight loss, and oral appliances may be appropriate in select cases, particularly for mild OSAS. Following initial treatment, all children should be monitored for residual symptoms and polysomnography may be repeated to identify persistent disease, which can be managed with positive airway pressure ventilation and additional surgical approaches if required.
阻塞性睡眠呼吸暂停综合征(OSAS)是一种常见的儿科疾病,其特征是睡眠期间上呼吸道部分或完全阻塞反复发作,导致通气和睡眠模式异常。儿童 OSAS 与神经行为缺陷和心血管发病率有关,这突出表明需要及时识别、诊断和治疗。本综述旨在介绍儿童 OSAS 的评估和管理的最新进展,重点关注伴有复杂医学合并症的儿童和一线治疗后仍存在 OSAS 的儿童。提出了反映各种专业协会建议的治疗策略。所有儿童都应进行 OSAS 筛查,对于有典型症状(如打鼾、睡眠不安和日间多动)或有风险因素(如神经、遗传和颅面畸形)的儿童,应进一步评估,包括转介给睡眠专家或儿科耳鼻喉科医生进行夜间多导睡眠图检查,以明确诊断。对于高危儿童,应考虑进行心脏病学和/或内分泌学评估。对于大多数儿童,一线治疗是扁桃体切除术加或不加腺样体切除术;然而,一些儿童存在多个气道阻塞水平,可能需要进一步评估和治疗。在特定情况下,抗炎药物、减肥和口腔矫治器可能是合适的,特别是对于轻度 OSAS。初始治疗后,所有儿童都应监测残留症状,并且可能需要重复多导睡眠图以识别持续存在的疾病,如有必要,可以使用气道正压通气和其他手术方法进行治疗。